Bio Medica Laboratories
Table of Contents
- 01 IPO Description
- 02 IPO Parameters
- 03 IPO Roadmap
- 05Bio Medica Laboratories IPO Market Lot
- 05 Bio Medica Laboratories IPO Details
- 06 IPO Reservation<
- 07 Bio Medica Laboratories IPO Dates
- 08 Promoters and Holding Pattern
- 09 Objects of the Issue & Utilisation of Proceeds
- 10 About Bio Medica Laboratories IPO
- 11 Bio Medica Laboratories IPO Company Financial Report
- 12 Bio Medica Laboratories IPO Valuation – FY2025
- 13 Peer Group Comparison
- 14 IPO Lead Managers aka Merchant Bankers
IPO PARAMETERS
IPO ROADMAP
Bio Medica Laboratories IPO MARKET LOT
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 2,000 | ₹278,000 |
| Retail Maximum | 2 | 2,000 | ₹278,000 |
| S-HNI Minimum | 3 | 3,000 | ₹417,000 |
| S-HNI Maximum | 7 | 7,000 | ₹973,000 |
| B-HNI Minimum | 8 | 8,000 | ₹1,112,000 |
Bio Medica Laboratories IPO DETAILS
| Particulars | Details |
|---|---|
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹132 to ₹139 Per Share |
| Issue Size | Approx ₹52.43 Crores, 37,72,000 Equity Shares |
| Fresh Issue | Approx ₹47.19 Crores, 33,95,000 Equity Shares |
| Offer for Sale | Approx ₹5.24 Crores, 3,77,000 Equity Shares |
| Issue Type | Book Build Issue |
| IPO Listing | NSE SME |
IPO RESERVATION<
| Investor Category | Share Offered | Shares (%) |
|---|---|---|
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 36,000 Shares | 50% |
| NII Shares Offered | 17,55,000 Shares | 15% |
| Retail Shares Offered | 17,92,000 Shares | 35% |
Bio Medica Laboratories IPO DATES
The Bio Medica Laboratories IPO date is May 21 and the close date is May 25. The Bio Medica Laboratories IPO allotment will be finalized on May 26 and the IPO listing on May 28.
| Event | Date |
|---|---|
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Basis of Allotment | May 26, 2026 |
| Refunds | May 27, 2026 |
| Credit to Demat Account | May 27, 2026 |
| IPO Listing Date | May 28, 2026 |
| IPO Bidding Cut-off Time | May 25, 2026 – 5 PM |
Promoters and Holding PATTERN
The promoters of the company are Mr. Mukesh Mehta and Mr. Pradeep Mehta.
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 91,80,001 | 99.99% |
| Promoter Holding Post Issue | 1,25,74,801 | -% |
Objects of the Issue & Utilisation of PROCEEDS
| Purpose | Crores |
|---|---|
| Repayment of Loan | ₹7.25 |
| Enhancement of its Existing Production Capabilities by Setting Up of New Manufacturing Facility at the Existing Premises | ₹24.81 |
| General Corporate Purpose | ₹- |
About Bio Medica Laboratories IPO
Bio Medica Laboratories is one of the leading manufacturers of parenteral medicines (injectable products) in India. The firm has been involved in developing a wide range of parenteral medicines targeting both human and animal needs. They manufacture generic medicines in the form of Liquid injections and dry powder injections, which come in various forms of packaging like ampoules and vials.
The company also claims to offer high-quality and safe products, followed by Good Manufacturing Practices (GMP and GLP). Moreover, the company has built a reputation for providing reliable yet effective solutions in the healthcare industry. Its product range includes injectables for the domestic market, Injectables for export, and Injectables for veterinary.
Bio Medica Laboratories IPO Company Financial REPORT
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹16.25 | ₹15.80 | ₹0.33 | ₹17.57 |
| 2024 | ₹15.34 | ₹11.69 | ₹2.50 | ₹19.53 |
| 2025 | ₹38.33 | ₹25.18 | ₹9.79 | ₹39.12 |
| Nov 2025 | ₹28.63 | ₹16.95 | ₹8.66 | ₹65.17 |
Bio Medica Laboratories IPO Valuation – FY2025
Check Bio Medica Laboratories IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
|---|---|
| ROE | 99.59% |
| ROCE | 48.20% |
| EBITDA Margin | 39.83% |
| PAT Margin | 25.64% |
| Debt to Equity Ratio | 1.02 |
| Earning Per Share (EPS) | ₹10.67 (Basic) |
| Price/Earning P/E Ratio | N/A |
| Return on Net Worth (RoNW) | 99.59% |
| Net Asset Value (NAV) | ₹16.05 |
Peer Group COMPARISON
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Zenotech Laboratories Limited | 0.92 | – | 6.01% | 15.76 | 5.61 Cr. |
| Shukra Pharmaceuticals Limited | 0.22 | 47.57 | 15.90% | 1.43 | 9.58 Cr. |
IPO Lead Managers aka Merchant BANKERS
- Narnolia Financial Services Ltd.